Somatic mutations in DNMT3A are commonly identified as clonal hematopoiesis of indeterminate potential (CHIP) in healthy elderly adults without blood cancers [73] and has been associated with cardiovascular events [74–76]. This evidence concerns the gene DNMT3A and hematopoietic and lymphoid system neoplasm.